Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: /api Disallow: /search Disallow: /documents Allow: / Sitemap: |
Title | NEXT |
Description | Discover the ASX listed small cap stocks that the experienced team at Next Investors are investing in |
Keywords | N/A |
WebSite | nextbiotech.com.au |
Host IP | 104.21.36.64 |
Location | United States |
Site | Rank |
US$1,061
Last updated: 2023-05-07 21:06:42
nextbiotech.com.au has Semrush global rank of 0. nextbiotech.com.au has an estimated worth of US$ 1,061, based on its estimated Ads revenue. nextbiotech.com.au receives approximately 122 unique visitors each day. Its web server is located in United States, with IP address 104.21.36.64. According to SiteAdvisor, nextbiotech.com.au is safe to visit. |
Purchase/Sale Value | US$1,061 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$29 |
Yearly Ads Revenue | US$352 |
Daily Unique Visitors | 8 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nextbiotech.com.au. | A | 299 | IP: 104.21.36.64 |
nextbiotech.com.au. | A | 299 | IP: 172.67.186.194 |
nextbiotech.com.au. | AAAA | 300 | IPV6: 2606:4700:3030::6815:2440 |
nextbiotech.com.au. | AAAA | 300 | IPV6: 2606:4700:3037::ac43:bac2 |
nextbiotech.com.au. | NS | 86400 | NS Record: janet.ns.cloudflare.com. |
nextbiotech.com.au. | NS | 86400 | NS Record: mario.ns.cloudflare.com. |
nextbiotech.com.au. | MX | 300 | MX Record: 10 aspmx2.googlemail.com. |
nextbiotech.com.au. | MX | 300 | MX Record: 10 aspmx3.googlemail.com. |
nextbiotech.com.au. | MX | 300 | MX Record: 1 aspmx.l.google.com. |
nextbiotech.com.au. | MX | 300 | MX Record: 5 alt1.aspmx.l.google.com. |
nextbiotech.com.au. | MX | 300 | MX Record: 5 alt2.aspmx.l.google.com. |
nextbiotech.com.au. | TXT | 300 | TXT Record: v=spf1 include:_spf.google.com include:amazonses.com ~all |
nextbiotech.com.au. | TXT | 300 | TXT Record: google-site-verification=bg0nMuEtuS60EcSE-wNdKiSiknTRrmQz8o8MErAjTZQ |
nextbiotech.com.au. | TXT | 300 | TXT Record: facebook-domain-verification=bt04zug9thq5yka6qqsc0c33g2zvpd |
search Portfolio Next Investors Catalyst Hunter Wise-Owl Finfeed Latest Articles Quick Takes Education Macro Themes Trust Enter your email SUBSCRIBE Portfolio Next Investors Catalyst Hunter Wise-Owl Finfeed Latest Articles Quick Takes Education Macro Themes Trust search Subscribe Home Next Biotech Next Biotech Learn More about Next Investors - Experts in Biotech Stocks DXB: Making Strong Progress on “Main Bet,” Side Bet #2 Paused Next Investors Feb 28, 2022 Our 2021 Biotech Pick of the Year Dimerix (ASX:DXB) released its half year report last Thursday, updating investors on ethics approvals for its Phase III clinical trial for FSGS (a rare kidney disease) and closing in on important milestones for TWO of its Phase III COVID-19 studies. New Portfolio Addition: Arovella Therapeutics Next Investors Feb 18, 2022 Today we are finally announcing a new investment in the Next Investors portfolio. Arovella Therapeutics (ASX:ALA) is a small ASX biotech going after a unique solution to the |
HTTP/1.1 301 Moved Permanently Date: Thu, 28 Oct 2021 18:39:06 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Thu, 28 Oct 2021 19:39:06 GMT Location: https://nextbiotech.com.au/ Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=bFFImTzPc5xxzD%2Bnmrwg0SolmlFSKTMXwcfFdihPWFEE5CGYG6inGG9HX7F%2BVEbOXZSVlPk07zbjy8XmDq8y8vE%2FpKMQkR1QKkb6%2FKKQXFdqXokfHA8CUHMusKNBVh3MxZE2GhU%3D"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} Server: cloudflare CF-RAY: 6a5648f0e8c32c17-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 HTTP/2 301 date: Thu, 28 Oct 2021 18:39:06 GMT content-type: text/html location: http://www.nextbiotech.com.au/ cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=XJ9h9efPD%2FcvsCpzo4aA97PFcmI5So%2BzE%2FORn6QtU%2F4vpQnDXWqaKWXvM3SxynY%2FMj4KKqiXpibcj%2F4VgLER%2F%2FHqjv6MvC5oxfScArqPEf9UwNOjRu4RU9tqd%2FxR5TxRz271q18%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 6a5648f13d33616e-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 HTTP/1.1 301 Moved Permanently Date: Thu, 28 Oct 2021 18:39:07 GMT Connection: keep-alive Cache-Control: max-age=3600 Expires: Thu, 28 Oct 2021 19:39:07 GMT Location: https://www.nextbiotech.com.au/ Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=fqv4YOnWH0L%2BqcF52UboJ%2BgpP8M3CO75jFPfuuZfgtboM356vszMlsaMpWyJsnOALGH2vwQ08ivhhWhttEGZvvbcBSAAA2SbtW3oYqq7DLXJVMWvyAXKbzoxMY3TIpfG17tGW1hQeQKh"}],"group":"cf-nel","max_age":604800} NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} Server: cloudflare CF-RAY: 6a5648f4c91d2a12-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 HTTP/2 200 date: Thu, 28 Oct 2021 18:39:07 GMT content-type: text/html; charset=utf-8 vary: Accept-Encoding vary: Cookie x-frame-options: SAMEORIGIN cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=ge4Zv9Ke3BQ6PYuCj7PY1aQD2AOFfBYFYq4CYe7V5zBldekkr0JIu67h5CJz3HYmsIXN%2FciGV5YSNwGqNlmRxzaTOjH2YxHLHFUVg86%2Bq58gXm37Laidu2CNTNqmujcsmMS6Beyd6XsS"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 6a5648f51c686300-ORD alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 |